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The Phanerochaete chrysosporium ME446 cbhI.2 cDNA was cloned and expressed in Escherichia coli 
using a pET system. Pulse-labelling revealed the expression of an induced protein of approximately 50-
60 kDa that reacted with anti-P. chrysosporium ME446 CBH antibodies. The expressed protein remained 
undegraded in vivo for 135 min but was biologically inactive in vitro.       
 





The importance of lignocellulose biotechnology and the 
many potential applications of lignocellulose enzymes in 
various industries such as chemicals, fuel, food, brewery 
and wine, animal-feed, pulp-and-paper, textile and 
agriculture are well documented (Gavrilescu and Chisti, 
2005; Howard et al., 2003; Bhat, 2000; Sun and Cheng, 
2002).  Phanerochaete chrysosporium, being an efficient 
degrader of lignin, hemicellulose and cellulose, the major 
constituent components of lignocellulose, is suitable for 
various industrial applications. Also, it is an appropriate 
organism for studying the interaction of genes and 
enzymes involved in the complex lignocellulose 
degradation process.       
Multiple, non-allelic, cellobiohydrolase (cbh)-like 
sequences/genes, which are likely to be involved in 
cellulose degradation, have been identified (Covert et al., 
1992; Sims et al., 1994).  Two of these sequences/genes, 
namely, cbhI.1 and cbhI.2 were characterised from 
genomic and cDNA libraries (Sims et al., 1994). Howard 
et al. (2004) reported on cbhI.1, and hence cbhI.2 is the 
focus of this report. The sequence data for P. 
chrysosporium ME446 cbhI.2 appears in the 
EMBL/GenBank/DDBJ Sequence Data Library under the 
accession numbers Z22527 (genomic) and Z29653 
(cDNA).  cbhI.2 has two internal introns at the same 
positions as cbhI.1 but with different sequences, and a 
single up-stream intron whereas cbhI.1 has two up-
stream introns. One of cbhI.2 internal introns near the 3´-
end was shown to be excised from only some of the 
cDNA library clones (Sims et al., 1994).  Since this 
“intron” contains no stop codon, it means translation of 
mRNA containing this “intron” will produce a “CBHI.2” 
with a significantly altered C-terminus (Broda et al., 1994; 
Birch et al., 1995).  Hence two “CBHI.2” proteins could 
theoretically be formed either through selective alteration 
of CBHI.2 at protein level or differential splicing at mRNA 
level. Some cellulases may regulate their substrate 
specificities through proteolytic removal of their C-
terminus (Knowles et al., 1987) while another mechanism 
maybe differential removal of the 3´ intron (Broda et al., 
1994; Birch et al., 1995).  Birch et al. (1995) 
demonstrated that two types of mRNA are produced for 
P. chrysosporium ME446 cbhI.2 and that differential 
splicing of the 3´ intron is substrate dependent. We still 
do not know whether both mRNAs are translated, the 
nature of the proteins and the mechanisms involved in 
cellulose hydrolysis. Cloning and expression of the two 
forms of cDNA (with and without the “3´ intron”) will assist 
in addressing the latter issues. 
Previous, unsuccessful, attempts were made to 
express cbhI.2 in Escherichia coli using pUC18 and 
pKKScxyl(H) vectors (Howard, 1997). This study 
investigated cloning and expression of cbhI.2 in E. coli 
using a pET system.  
 
 
MATERIALS AND METHODS 
 
Strains and vectors  
 
E. coli BL21 or E. coli (DE3)pLysS transformed with pET-22b(+) 
with or without the gene insert were used as expression hosts.  





Antibodies    
 
Anti-rabbit IgG alkaline phosphatase-conjugated (Promega) diluted 
1:7500 in Tris Buffered Saline Tween 20 (10mM Tris-HCl, pH 8.0, 
150 mM NaCl, 0.05% Tween 20) was used as a secondary 
antibody. Rabbit anti-P. chrysosporium ME446 CBH synthetic 
peptide, E. coli depleted, antibody (CBH-No 3) was supplied by the 
Lignocellulose Group, University of Manchester Institute of Science 
and Technology, Manchester, UK.  A 2000-fold-diluted antiserum 





The sequence data for P. chrysosporium ME446 cbhI.2 appears in 
the EMBL/GenBank/DDBJ Sequence Data Library under the 
accession numbers Z22527 (genomic) and Z29653 (cDNA).  Clone 
E. coli XL1-Blue-pUC18cbhI.2(H) carrying the fully-spliced cbhI.2 
cDNA open reading frame encoding the mature CBHI.2 protein was 
previously constructed (Howard, 1997).  A 1.6 kb HindIII fragment 
containing the cbhI.2 opening reading was isolated from the latter 





Clone E. coli XL1-Blue-pUC18cbhI.2(H) was grown on Luria-Bertani 
(LB) broth or solid media containing 50 g/ml cabenicillin at 37oC.  
E. coli BL21(DE3)pLysS was grown on LB media containing 34 
g/ml chloramphenicol at 37oC and when transformed with pET, 50 
g/ml cabenicillin was also added to the same media.        
 
 
DNA manipulations and colony hybridisation 
 
Mini-prep DNA isolation, restriction endonuclease digestion, ligation 
and transformation, agarose gel electrophoresis and colony 
hybridisation were performed according to standard methods 
described by Sambrook et al. (1989).  Both pUC18cbhI.2(H) and 
pET were separately digested with HindIII and separated on 
agarose by  electrophoresis. The Hind III cbhI.2 fragment of 
approximately 1.6 kb and the linearised pET vector were purified 
from the agarose gel using QIAGEN Agarose Gel DNA Extraction 
Kit according to the manufacturer’s instructions.  To prevent self-
religation of the vector, purified, linearised vector was 
dephosphorylated using calf intestinal alkaline phosphatase (CIP) 
(Promega) and repurified following standard methods (Sambrook et 
al., 1989). The purified cbhI.2 was then religated to the pET vector 
and transformed into competent E. coli BL21 cells for vector 
amplification, repurified from the latter host and transformed into 
competent E. coli (DE3)pLysS for protein expression. 
Transformants were screened for clones carrying pETcbhI.2 using 
colony hybridisation. The purified HindIII cbhI.2 was random primed 
labelled using either radioactive α-32PdATP (Sambrook et al., 1989) 
or Digoxigenin (DIG) Labelling Kit (Boehringer) according to the 
manufacturer’s instructions; and the labelled cbhI.2 was used as a 
probe in the colony hybridisation screening.    
 
 
PCR and DNA sequencing 
 
Plasmids used for sequencing were purified using a QIAprep 
miniprep kit (QIAGEN).  PCR amplification was done using the ABI 
PRISMTM Dye Terminator Cycle Sequencing Ready Reaction Kit 
(Perkin Elmer) and cycle-sequenced on an ABI 373 Automatic 
Fluorescence Sequencer (Perkin Elmer), according to the 
manufacturer’s instructions (Perkin Elmer, protocol P/N 402078, 
revision      A,      1995).      The      T7      promoter      primer      5´- 




TAATACGACTCTATAGG (Novagen) was used in DNA sequencing 
to verify the 5´ DNA region spanning: the pET promoter, signal 
peptide encoding sequence and cbhI.2 sequence.   
 
 
Protein blotting and immuno-detection 
 
Dot blots and Western blots were prepared according to standard 
procedures (Sambrook et al., 1989). Ten-fold concentrated 
supernatant from P. chrysosporium grown on ball-milled straw was 
used as a positive control. The immuno-detection was done using 
the ProBlot® Western Blot AP System (Promega) according to the 
manufacturer’s instructions.  
 
 
Radioactive pulse-labelling and chase  
 
Radioactive labelling, chasing and autoradiographic analyses were 
essentially done according to the method described by S. Tabor 
(Department of Biological Chemistry, Harvard Medical School, 
Boston, MA 02115).  A single colony of an overnight culture (E. coli 
BL21 transformed with pET only or pETcbh1.2) was inoculated into 
5 ml LB media the appropriate antibiotics as mentioned under 
media section. Cultures were incubated overnight at 37oC with 
shaking. 100 l of the overnight culture was transferred to an 
Eppendroff tube and 500 l of pre-warmed (37oC) LB broth media 
containing the appropriate antibiotics was added.  The culture was 
mixed by vortexing briefly, centrifuged at 13,000 rpm for 30 s and 
the pellet was resuspended in 100 l of the same media as before. 
The later culture was further diluted 1:40 in the same LB media. 
The culture was incubated at 37oC for 3 to 4 h with shaking and 
until cell density reached an OD590nm ≈  0.5.  One microlitre of the 
latter culture was centrifuged at 13,000 rpm for 30 s, washed with 5 
ml pre-warmed (37oC) 2 x M9/1% glucose media (Sambrook et al., 
1989), briefly vortexed and centrifuged as previously. The cell pellet 
was resuspended in 2 ml pre-warmed 1 x M9 media containing 
0.5% glucose, 0.02% mixture of 18 amino acids (except cysteine 
and methionine) and 0.5% thiamine.  Cells were grown with shaking 
at 37oC for 60 min to deplete methionine reserves, so that 
radioactive-labelled methionine was readily used in protein 
synthesis. One millilitre of the culture was induced with 1 mM IPTG 
for 20 min and the other 1 ml served as the un-induced culture. 
Rifampicin to a final concentration of 200 g/ml was added to both 
the induced and un-induced cultures to inhibit E. coli RNA 
polymerase and cultures were incubated at 37oC with shaking. After 
15-20 min 10 Ci 35S-methionine was added to both cultures and 
the cells were incubated at 37oC with shaking for 10 to 20 min. The 
cells were harvested at 13,000 rpm for 20 s and analysed for 
protein content. Supernatant fluid, whole cell and various fractions 
obtained from the periplasm, cytoplasm, insoluble fraction 
(membrane and inclusion bodies) were prepared according to 
procedures described by Sambrook et al. (1989). Supernatant fluid, 
whole cell and the various fractions were analysed using SDS-
PAGE, and stained or unstained cling-wrapped gels were 
autoradiographed at room temperature for 1-7 days (Sambrook et 
al., 1989).   
The stability of the expressed proteins were monitored following 
the same procedure as for the labelling experiment, except that 
cells were pulse-labelled for 15 min and chased using non-
radioactive methionine at a final concentration of 0.5%.  At intervals 
of 45, 90 and 135 min after incubation 0.5 ml aliquots were 
removed centrifuged as before and the whole cell proteins were 
analysed by SDS-PAGE and autoradiography as indicated above.            
 
 
Crude protein extract 
 
Single colonies of cells carrying pET and pETcbhI.2(H), 
respectively,   were   separately   inoculated   into   5 ml   LB   broth  




containing the appropriate antibiotics 50 µg/ml cabenicillin and 34 
µg/ml chloramphenicol, and grown overnight at 37oC in a shaker 
incubator.  One hundred microlitres of each culture was washed 
with fresh LB broth containing the appropriate antibiotics, 
centrifuged at 13,000 rpm for 30 s and resuspended in fresh media.  
These cultures were diluted 1:40 into fresh LB broth containing the 
appropriate antibiotics and grown with shaking at 37oC until the cell 
density reached an OD590nm of approximately 0.8-1.0.  Cells were 
then induced with 1 mM final concentration of IPTG for 30 min at 
30oC, after which rifampicin was added to a final concentration of 
200 µg/ml.  After 2 h cells were harvested by centrifugation at 4500 
rpm for 10 min at room temperature.  Cells were resuspended in 4 
ml of 50 mM TE buffer pH 6.8 containing 10 mM DTT, 174 µg/ml 
PMSF and ß-mercaptoethanol (1:1000). The cells were lysed by 
successive cycles of freezing (liquid nitrogen) and thawing by 
sonication for 20 s at half power (14 mA) until a clear cell lysate was 
obtained. This mix was used as crude protein extracts or 
alternatively the sonicated mixture was centrifuged at 13,000 rpm 
for 2 min to remove cell debris, and this cleared supernatant fluid 
was used as crude proteins extracts.    
The crude protein extracts and cellular fractions regarded as 
crude enzyme extracts were collected, assayed or aliquoted and 





Plate assays using either cells or crude enzyme extracts were 
performed according to the method of Teather and Wood, (1982) 
on 0.5% w/v CMC and 0.5% w/v Avicel, separately. Crude enzyme 
extracts were also assayed for activity using the method described 
by Bailey and Poutanen (1989) for the formation of reducing sugars 
from 0.5% w/v CMC or Avicel in 50 mM citrate buffer pH 5 at 50oC.  
Alternatively, crude enzymes were tested for activity using two other 
methods: one as described by Laymon et al. (1996) for hydrolysis 
of 0.5 mM 4-methylumbelliferyl-ß-D-cellobioside/lactopyranoside 
(MUC or MUL) (Sigma) in 50 mM sodium acetate buffer pH 5 at 
50oC. And the other method as described by Cummings and Fowler 
(1996) for hydrolysis of 2 mM p-Nitrophenyl-cellobioside/lactoside 





Colony hybridisation and DNA sequencing 
 
Eight positive clones carrying the cbhI.2 DNA sequence 
were identified using plate hybridisation. DNA sequencing 
revealed that only two of the eight clones carried the 
cbhI.2 sequence in the correct orientation and in-frame to 
the sequence encoding the signal peptide.  One of these 
clones designated pETcbhI.2(H) was subsequently used 
in all further experiments.   
 
 
Pulse-labelling and chase 
 
The protein bands of expected size (Figure 1) were 
observed in whole cell extracts (lane 5) and in the 
insoluble fraction (membrane and inclusion bodies) (lane 
8), from induced pETcbhI.2(H) cells.  Comparison of a 
Comassie-stained SDS-PAGE loaded with the same 





markers, and electrophoresed in parallel with the gel 
prepared for autoradiography was used to visually 
estimate the size of the positive bands and these were 
estimated to be approximately between 50-60 kDa. 
Interestingly, in each of the positive fractions duplex 
signals were present. No positive signals corresponding 
in size to the expected CBHI.2 protein were observed in 
the soluble periplasmic (lane 6) or soluble cytoplasmic 
(lane 7) fractions.  None of the fractions from induced 
cells carrying the pET vector only showed any positive 
signals corresponding in prominence to those found in 
lanes 5 and 8 of pETcbhI.2(H).  The signal intensity for 
the induced protein (whole cell extracts) from 
pETcbhI.2(H) remained almost constant throughout the 
chase periods of 45, 90 and 135 min (lanes 1-3) (Figure 




Figure 1. An autoradiograph showing signals from pulsed labelled 
proteins.  Lanes 1-4 contained whole cell extract, soluble 
periplasmic, soluble cyptoplasmic and insoluble fractions, 
respectively from induced pET only cells.  Lanes 5-8 contained the 
same extract and fractions, respectively, as for the latter cells but 
these were obtained from induced pETcbhI.2 cells.  The top arrow 
indicates the estimated size of the nearest molecular mass 




             
Figure 2. An autoradiograph of pulse-labelled and chased whole cell 
extract proteins from induced pETcbhI.2.  Cells were labelled for 15 












Figure 3. Dot Blot (a) and Western blot (b).  a1 and b1, positive 
controls; a2 and b3, pETcbhI.2(H); and a3 and b2, pET only.  
 
 
Dot-blot and western blot 
 
Positive reactions with CBH-No 3 antibody were 
observed in both the dot-blot and Western blot (Figures 
3a and 3b, respectively) for insoluble fractions from 
induced pETcbhI.2(H) and the positive controls but no 
reaction occurred with crude protein extracts from 





Although the cDNA coding for mature CBHI.2 was 
successfully fused in frame to the pelB signal peptide 
sequence of the pET vector various enzyme assays 
showed no activity and no proteins consistent with the 
theoretical predicted size of approximately 56.2 kDa 
(correctly processed CBHI.2 without the pelB signal 
peptide) or 58.7 kDa (CBHI.2 still containing pelB signal 
peptide) were detected using SDS-PAGE analysis. These 
observations suggested that either no expression 
occurred or that a very low undetectable level of an 
inactive gene-product was made.  Results from the pulse-
labelling experiments demonstrated that expression did 
occur. Since the presumptive CBHI.2 protein was not 
present in the supernatant fluid or soluble fractions but 
only in the whole cell and insoluble fractions suggested 
that this protein was insoluble.  Most  eucaryotic  proteins  




expressed in E. coli often accumulate within the cell as 
insoluble protein aggregates or inclusion bodies which 
are biologically inactive (Guise et al., 1996; Cardamone 
et al., 1995; Doyle and Smith, 1996).   
Two closely associated bands consistent with the 
predicted CBHI.2 size were observed in the insoluble 
fractions for induced pETcbhI.2. The sizes of these bands 
suggested that these proteins were two forms of 
presumptive CBHI.2; the top band represented 
unprocessed CBHI.2, still carrying the signal peptide 
amino acid sequence, and the lower band the fully 
spliced protein. It is interesting to note while the signal 
peptide appeared to have been correctly processed in 
one variant form of the presumptive CBHI.2, this protein 
did not appear to have been transported across the 
cyptoplasmic membrane since no signal for this protein 
was detected in the periplasm. Transport of protein 
across the cyptoplasmic membrane involves various 
transport factors, including various host cell proteins such 
as docking proteins, SRP and SecB-dependent 
complexes, and chaperons (Fekkes and Driessen, 1999).  
Addition of rifampicin inhibits host RNA polymerase and 
this might have limited expression of all the necessary 
host proteins required for efficient transport of 
presumptive CBHI.2.   
The pET 22b is driven by a strong, lac inducible, 
selective T7 RNA bacteriophage promoter and the host 
BL21 cell carries the genes for a lac inducible T7 RNA 
polymerase that selectively drives transcription of genes 
cloned in-frame to the T7 RNA promoter.  This unique 
vector-host combination allows for high-level expression 
of foreign genes, almost 50% of total cell proteins 
(Novagen), however, in the case of the presumptive 
CBHI.2 the expression level appears to be much lower 
since expressed proteins could not be detected by SDS-
PAGE analysis but only by radioactive-labelling.  
Expression of eukaryotic genes in E. coli is not always 
efficient.  Makrides (1996) reviews the various factors 
which might influence expression, some of these include: 
major differences in codon usage between the foreign 
gene and native E. coli genes, stability and translational 
efficiency of the foreign-gene’s mRNA, unique and subtle 
gene sequence organisation differences, vector stability 
and copy number, inadequate protein folding, protein-
degradation and toxicity of the foreign protein to E. coli.  
But in this study we eliminated the possibility that the low 
level accumulation of presumptive CBHI.2 was due to 
instability, i.e. the protein was significantly degraded by 
host proteases. Teeri (1987) observed that T. reesei 
CBHI expressed as a non-fused protein in E. coli was 
rapidly degraded by host proteolytic enzymes.   Almost 
50% of labelled proteins with abnormal structures were 
degraded within the first hour in E. coli  (Prouty and 
Goldberg,  1972).   Since  the  signal  intensity remained 
constant during the chase periods and did  not decrease 
with time suggested that the presumptive  CBHI.2  was 
stable. So it is not clear which of  the  other  factors  were  




responsible for the low level expression.     
The  size  of  the  positive  signals  from   the   labelling  
experiment and the fact that these signals were only 
present in induced pETcbh1.2(H) cells were compelling 
evidence that the protein might be CBHI.2 but this did not 
rule out the possibility of some spurious gene-product 
since none of the enzyme assays showed any cellulolytic 
activity. But the results from the dot- and Western blots 
make the latter highly unlikely and hence from the 
collective evidence it is concluded that a biological 
inactive CBHI.2 was successfully expressed from E. coli. 
A conclusion that is further supported and reported on in 
the second part dealing with the chemical refolding and 
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